Human alpha-1 Proteinase Inhibitor class drugs

3 results

Glassia (alpha.1-proteinase inhibitor human)

(ALPHA.1-PROTEINASE INHIBITOR HUMAN)
Takeda Pharmaceuticals America, Inc.
Usage: GLASSIA is indicated for chronic augmentation and maintenance therapy in individuals with emphysema due to severe hereditary Alpha-1 Proteinase Inhibitor deficiency (AAT deficiency). Its effects on pulmonary exacerbations and emphysema progression are not conclusively demonstrated. It is not for use in patients without established severe deficiency.
GRIFOLS USA, LLC
Usage: PROLASTIN-C LIQUID is indicated for chronic augmentation and maintenance therapy in adults with emphysema due to severe hereditary Alpha-1 Proteinase Inhibitor deficiency. Its effects on pulmonary exacerbations and emphysema progression are not conclusively demonstrated, and it is not for use without established deficiency.

Zemaira (alpha-1-proteinase inhibitor human kit)

(alpha-1-proteinase inhibitor human kit)
Fisher Clinical Services Inc.